[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Prescription Dermatology Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

November 2018 | 119 pages | ID: G117FD78599GEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SCOPE OF THE REPORT:

Based on product types,the psoriasis drugs segment dominated the global market prescription dermatology therapeutics in 2017.
The global Prescription Dermatology Therapeutics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Prescription Dermatology Therapeutics.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Prescription Dermatology Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Prescription Dermatology Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
  • Pfizer
  • AbbVie
  • Johnson & Johnson
  • Novartis
  • Amgen
  • Eli Lilly
  • Celgene
  • LEO Pharma
  • Bausch Health Companies
  • Sun Pharmaceutical
  • Aclaris Therapeutics
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Fungal Infection Drugs
  • Skin Cancer Drugs
  • Acne & Rosacea Drugs
  • Psoriasis Drugs
  • Dermatitis & Seborrhea Drugs
Market Segment by Applications, can be divided into
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
1 PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Prescription Dermatology Therapeutics
1.2 Classification of Prescription Dermatology Therapeutics by Types
  1.2.1 Global Prescription Dermatology Therapeutics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Prescription Dermatology Therapeutics Revenue Market Share by Types in 2017
  1.2.3 Fungal Infection Drugs
  1.2.4 Skin Cancer Drugs
  1.2.5 Acne & Rosacea Drugs
  1.2.6 Psoriasis Drugs
  1.2.7 Dermatitis & Seborrhea Drugs
1.3 Global Prescription Dermatology Therapeutics Market by Application
  1.3.1 Global Prescription Dermatology Therapeutics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Prescription Dermatology Therapeutics Market by Regions
  1.4.1 Global Prescription Dermatology Therapeutics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Prescription Dermatology Therapeutics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Prescription Dermatology Therapeutics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Prescription Dermatology Therapeutics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Prescription Dermatology Therapeutics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Prescription Dermatology Therapeutics Status and Prospect (2013-2023)
1.5 Global Market Size of Prescription Dermatology Therapeutics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Prescription Dermatology Therapeutics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.2 AbbVie
  2.2.1 Business Overview
  2.2.2 Prescription Dermatology Therapeutics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 AbbVie Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
  2.3.1 Business Overview
  2.3.2 Prescription Dermatology Therapeutics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Johnson & Johnson Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
  2.4.1 Business Overview
  2.4.2 Prescription Dermatology Therapeutics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Novartis Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
  2.5.1 Business Overview
  2.5.2 Prescription Dermatology Therapeutics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Amgen Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Eli Lilly
  2.6.1 Business Overview
  2.6.2 Prescription Dermatology Therapeutics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Eli Lilly Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Celgene
  2.7.1 Business Overview
  2.7.2 Prescription Dermatology Therapeutics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Celgene Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.8 LEO Pharma
  2.8.1 Business Overview
  2.8.2 Prescription Dermatology Therapeutics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 LEO Pharma Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bausch Health Companies
  2.9.1 Business Overview
  2.9.2 Prescription Dermatology Therapeutics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Bausch Health Companies Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharmaceutical
  2.10.1 Business Overview
  2.10.2 Prescription Dermatology Therapeutics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
2.11 Aclaris Therapeutics
  2.11.1 Business Overview
  2.11.2 Prescription Dermatology Therapeutics Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET COMPETITION, BY PLAYERS

3.1 Global Prescription Dermatology Therapeutics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Prescription Dermatology Therapeutics Players Market Share
  3.2.2 Top 10 Prescription Dermatology Therapeutics Players Market Share
3.3 Market Competition Trend

4 GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET SIZE BY REGIONS

4.1 Global Prescription Dermatology Therapeutics Revenue and Market Share by Regions
4.2 North America Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
4.3 Europe Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
4.5 South America Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PRESCRIPTION DERMATOLOGY THERAPEUTICS REVENUE BY COUNTRIES

5.1 North America Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
5.2 USA Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
5.3 Canada Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
5.4 Mexico Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)

6 EUROPE PRESCRIPTION DERMATOLOGY THERAPEUTICS REVENUE BY COUNTRIES

6.1 Europe Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
6.2 Germany Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
6.3 UK Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
6.4 France Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
6.5 Russia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
6.6 Italy Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PRESCRIPTION DERMATOLOGY THERAPEUTICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
7.2 China Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
7.3 Japan Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
7.4 Korea Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
7.5 India Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PRESCRIPTION DERMATOLOGY THERAPEUTICS REVENUE BY COUNTRIES

8.1 South America Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
8.2 Brazil Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
8.3 Argentina Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
8.4 Colombia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PRESCRIPTION DERMATOLOGY THERAPEUTICS BY COUNTRIES

9.1 Middle East and Africa Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
9.3 UAE Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
9.4 Egypt Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
9.6 South Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)

10 GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET SEGMENT BY TYPE

10.1 Global Prescription Dermatology Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Global Prescription Dermatology Therapeutics Market Forecast by Type (2018-2023)
10.3 Fungal Infection Drugs Revenue Growth Rate (2013-2023)
10.4 Skin Cancer Drugs Revenue Growth Rate (2013-2023)
10.5 Acne & Rosacea Drugs Revenue Growth Rate (2013-2023)
10.6 Psoriasis Drugs Revenue Growth Rate (2013-2023)
10.7 Dermatitis & Seborrhea Drugs Revenue Growth Rate (2013-2023)

11 GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET SEGMENT BY APPLICATION

11.1 Global Prescription Dermatology Therapeutics Revenue Market Share by Application (2013-2018)
11.2 Prescription Dermatology Therapeutics Market Forecast by Application (2018-2023)
11.3 Hospital Pharmacies Revenue Growth (2013-2018)
11.4 Retail Pharmacies Revenue Growth (2013-2018)
11.5 Online Pharmacies Revenue Growth (2013-2018)

12 GLOBAL PRESCRIPTION DERMATOLOGY THERAPEUTICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Prescription Dermatology Therapeutics Market Size Forecast (2018-2023)
12.2 Global Prescription Dermatology Therapeutics Market Forecast by Regions (2018-2023)
12.3 North America Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
12.4 Europe Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
12.6 South America Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Prescription Dermatology Therapeutics Picture
Table Product Specifications of Prescription Dermatology Therapeutics
Table Global Prescription Dermatology Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Prescription Dermatology Therapeutics Revenue Market Share by Types in 2017
Figure Fungal Infection Drugs Picture
Figure Skin Cancer Drugs Picture
Figure Acne & Rosacea Drugs Picture
Figure Psoriasis Drugs Picture
Figure Dermatitis & Seborrhea Drugs Picture
Table Global Prescription Dermatology Therapeutics Revenue (Million USD) by Application (2013-2023)
Figure Prescription Dermatology Therapeutics Revenue Market Share by Applications in 2017
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Prescription Dermatology Therapeutics Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Prescription Dermatology Therapeutics Type and Applications
Table Pfizer Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Prescription Dermatology Therapeutics Type and Applications
Table AbbVie Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Prescription Dermatology Therapeutics Type and Applications
Table Johnson & Johnson Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Prescription Dermatology Therapeutics Type and Applications
Table Novartis Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Prescription Dermatology Therapeutics Type and Applications
Table Amgen Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Prescription Dermatology Therapeutics Type and Applications
Table Eli Lilly Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Celgene Basic Information, Manufacturing Base and Competitors
Table Celgene Prescription Dermatology Therapeutics Type and Applications
Table Celgene Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Prescription Dermatology Therapeutics Type and Applications
Table LEO Pharma Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Prescription Dermatology Therapeutics Type and Applications
Table Bausch Health Companies Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Prescription Dermatology Therapeutics Type and Applications
Table Sun Pharmaceutical Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Aclaris Therapeutics Basic Information, Manufacturing Base and Competitors
Table Aclaris Therapeutics Prescription Dermatology Therapeutics Type and Applications
Table Aclaris Therapeutics Prescription Dermatology Therapeutics Revenue, Gross Margin and Market Share (2016-2017)
Table Global Prescription Dermatology Therapeutics Revenue (Million USD) by Players (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue Share by Players (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Share by Players in 2016
Figure Global Prescription Dermatology Therapeutics Revenue Share by Players in 2017
Figure Global Top 5 Players Prescription Dermatology Therapeutics Revenue Market Share in 2017
Figure Global Top 10 Players Prescription Dermatology Therapeutics Revenue Market Share in 2017
Figure Global Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue (Million USD) by Regions (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Market Share by Regions (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Market Share by Regions in 2017
Figure North America Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Europe Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure South America Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
Table North America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2017
Figure USA Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Canada Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Mexico Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Prescription Dermatology Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Europe Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Europe Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure UK Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure France Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Russia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Italy Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Prescription Dermatology Therapeutics Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2017
Figure China Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Japan Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Korea Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure India Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Prescription Dermatology Therapeutics Revenue by Countries (2013-2018)
Table South America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Argentina Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Colombia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Prescription Dermatology Therapeutics Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure UAE Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Egypt Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure Nigeria Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Figure South Africa Prescription Dermatology Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue Share by Type (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Share by Type (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Share by Type in 2017
Table Global Prescription Dermatology Therapeutics Revenue Forecast by Type (2018-2023)
Figure Global Prescription Dermatology Therapeutics Market Share Forecast by Type (2018-2023)
Figure Global Fungal Infection Drugs Revenue Growth Rate (2013-2018)
Figure Global Skin Cancer Drugs Revenue Growth Rate (2013-2018)
Figure Global Acne & Rosacea Drugs Revenue Growth Rate (2013-2018)
Figure Global Psoriasis Drugs Revenue Growth Rate (2013-2018)
Figure Global Dermatitis & Seborrhea Drugs Revenue Growth Rate (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue by Application (2013-2018)
Table Global Prescription Dermatology Therapeutics Revenue Share by Application (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Share by Application (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue Share by Application in 2017
Table Global Prescription Dermatology Therapeutics Revenue Forecast by Application (2018-2023)
Figure Global Prescription Dermatology Therapeutics Market Share Forecast by Application (2018-2023)
Figure Global Hospital Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Retail Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Online Pharmacies Revenue Growth Rate (2013-2018)
Figure Global Prescription Dermatology Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Prescription Dermatology Therapeutics Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Prescription Dermatology Therapeutics Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
Figure Europe Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
Figure South America Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Prescription Dermatology Therapeutics Revenue Market Forecast (2018-2023)


More Publications